SCHEMBL6565823

SCHEMBL6565823

COc1c(CCCO)cccc1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.38
CA2 P00918 2/20 0.37
ALOX5 P09917 1/20 0.36
PTGS2 P35354 1/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 1/20 0.35
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
ELANE P08246 1/20 0.33
PPARA Q07869 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA14 Q9ULX7 1/20 0.33
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GAA P10253 1/20 0.32
ABCB1 P08183 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568787 0.95 ALOX5 (0.39) NR1H4CA2ALOX5PTGS2ALDH1A1
SCHEMBL6567734 0.84 ALDH1A1 (0.36) CA2ALOX5PTGS2ALDH1A1KDM4E
SCHEMBL2675286 0.83 CA2 (0.34) CA2ALDH1A1KDM4EGABRA1GABRB2
SCHEMBL16154153 0.83 CA2 (0.42) NR1H4CA2ALDH1A1KDM4EGABRA1
SCHEMBL8401509 0.82 ALDH1A1 (0.36) NR1H4CA2ALDH1A1KDM4EGABRA1
SCHEMBL7933896 0.81 CYP4F2 (0.40) NR1H4ALDH1A1TDP1GAA
SCHEMBL8400748 0.81 ALDH1A1 (0.36) NR1H4CA2ALDH1A1KDM4ETDP1
SCHEMBL7796396 0.78 NR1H4 (0.47) NR1H4ELANE
SCHEMBL7943125 0.78 ALDH1A1 (0.43) NR1H4CA2ALDH1A1KDM4EGABRA1
SCHEMBL6567771 0.78 CA2 (0.55) CA2ALOX5PTGS2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1484334-A2 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-08 EP disclosed
US-20040225145-A1 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED 2004-11-11 US disclosed
EP-0823435-B1 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL CO (JP) 2001-11-21 EP disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
US-5889095-A OXYGEN AND HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-03-30 US disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040225145-A1 Process for producing phosphite PHOSPHO1, PLCG1, PLCG2 NR1H4 3081/4885CA2 167/4885ALOX5 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.